tonight on kqed newsroom, the opioid crisis. what bay area is doing to tackle endency and overdoses. the iran nuclear deal, we get an expert's take on what this means for foreign relations. plus, how three u.c. berkeley students are using their experse to combat terrorism. i'm thuy vu. we begin with the opioid crisis. marin county will sue a dozen companies for highly addi opioid medications. they're spang drug comnies to coup tax dollars they spent responding to the drug crisis. they include prescription painkillers and illegal drugs like heroin.

while opioid prescription rates erdose deaths o continue to rise nationally. in california more than 2,000 people died from opioid overdoses in 2016 according to the statebl department of pc health. joining me now to discuss different strategies to tackle this crisis are dr. scott zieger, an associate professor of medicine and kqed laura kleinman and brian washington. welcome to you all. >> thk you. >> dr. steiger, let's begin with definitions. what types of drugs are categorized as opioids? >> they're dived into twomain categories, opiates which are derived from the poppy plant, so that includes things like morphine, codeine, heroin and the more generic synthetice l xycodone, fentanyl, hydromorphone, those are in the broader category of opioid. >> how do legali presions

fuel this crisis? don't people need the drugs to manage their pain? >> so in the mid '90s with the introduction of ongting b oxycodonend name oxycontin, the number ofc prptions for opioids for pain increased dramatically, and that continued until about 2012at which point there's -- since then there's been a decrease in the number of prescriptions. the problem was that too many people had too manyoi o and too many brains being exposed to thatddictiveubstance led to some problems, namely that people beca addicted to those things and needed to make sure thatto they were able obtain chemical.id, that the problem is that if the doctor no longer prescribe it they no longer have access or the doctor is not available to give the prescription, the person still physically

dependent upon the substance and needs to figure out a way to have th happen. >> and that's what's led to the crisis we're seeing now notionally. i laura, you've been looking at this issue in the bay area. how bigbs the pm in the bay area and in california as a whole? >> as you mentioned, the number from 2016, it was over 20 deaths in california but when you look at the country, our rates of opioid deaths,they are not high -- not quite as high as the eastern states but then you look atfornia as a state and you break it down by county. our rates in the rural counties, they are in the same category as some places in st virginia. so they're quite -- it's quite . ba the san francisco bay area is not that. in 2016 we had just under 100 deaths in san francisco. >> i know that brianto washi in marin county, you have now filed a suit against opioid manufacturers and distributorss ac them essentially of falsely promoting the safety and

efficacy of their painkillers. this comes after 30 california counties decided to join a similar but separate suit. what is your legal premise this?d all of >> thank you. the core legal premise is that the distributors a th manufacturers misled physicians and the public that prescribing opioids was safe for use for genera chronic pain. they indicated that people only became addicted ra about a of 1%. turns out now current estimates are that addiction rate is about 50%. >> are you basically saying the companies knew about this, they saw the problem ceying and t chose not to do anything about it? >> that's correct. they relied on false evidence in distributing and marketing these drugs widely. >> and so there are tsny lawson this now across the country, right, involving hundreds of cities and counties nationally. what do you -- what is the scope of this? how large could it get? we saw, for example, in the 199 o 5 -- 1990s a lot of companies

were engaged in litigation for tobacco company. could it reach that scale? >> we hopeo. we hope that's a good comparison, the tobacco ga lion. we have over 400 cities and counties and states involved in the litigatio and weink the public health problem is of a similar magnitude and it similar solution. >> and so, laura, california is also taking legislative action on thiswe thi the state assembly passed a bill that basically limits doctors in most cases from prescribing more than five days worth of opioids to minors. that bill now goes to the senate. what's been the reaction this from the california medical a soeshags and oth doctors? >> the california medical association is opposed to it. ctors i've spoken to, one feels it's too little too late. >> why is the cma opposed to it? >> my understanding why they would be opposed to it is because it is getting into the

territory of what a doctor is doing in their ofdoctor's ice. the doctors i have spoken with, hey feel it's too little too late. regulation around prescription opioids, that's the firstphse of the opioid epidemic. now people have moved on to oi h fentanyl and those are deadly forms of opioids. so there's that view. and theno also doctors e prescribing opioids to kids, they have gotten a lot of this education athis point andso they're doing it in really severe cases. so these mighbe kids who are in hospice, kids who are periencing extreme amounts of pain. one doctor said if you limit what we can give foous, it have a really negative effect similar to what dr. steiger was saying, they have a dependency, they need to fulfill it elsewhere. re's saying, yes, let's get rid ofribing in the way we do, but it needs to happen slowly. it can't be legislated out slowly. >> dr. steiger, do you agree

that legislation is not an effective way dr s this? >> it depends on the legislation. don'ts particular piece i treat kids so i can't really speak with much authority about who needs pain relief through opioids or not in that -- that particular clinical setting, but i can sayett has notroven to put a curve on the number of overdose deaths oo a nal scale or in california and so it seems like maybe other ways of -- other kinds of legislativent ventions are -- would be more important for curbing the tide of death. marin county aside from the lawsuit, it's been pretty active in stepping up andfi ding a community-based solution to this. can you talk about that? >> that's correct. i canttalk a little about it. our public health department is leading an innovative program called rx marin working with the public, physicians, nonprofits

to make sure we're rachetting down the level of opioid presc'sptions. thaeen a successful effort the past few years. >> pretty innovativ it's a whole collaboration between law enforcement groups, doctor pharmacists, intervention specialists, right? >> that's correct. it's a problem that spans many disciplines and everyone's got to get involved in solving it and that's what rx safe marin is about. >> laura, iw you've been followingp on treatment programs. what types of treatments are available out there? >> there are a variety of treatmentsbl avai the most common are methadone and bup prey morphine and methadone is something that has more regulation around it. if someone is getting treated that way they would go to a methadone clinic. bne buprenorpould be more effective in rural counties for people that can't take that bush ride that's r and a half to a methadone clinic that's

hard to reach. another thing i've been following is efforts in san francisco which are really amazing around harm reduction. so this something for folks who are not yet ready to maybe transition to treatment but san francisco these things mean you can go to a needle exchange and you can get clean needles, clean syringes, you can even get little strips that test a drug to see if it has fentanyl in ite somewill probably still do that drug, but maybe if they know there'sn fentanyl it they will use less of it. they will use it with people around. another thing that we're doing in san francsco and other places around the state is distributing narcan, which is the opioid reversal drug. i went with one of these harm reduction individuals and she trained bartenders and people who work in clubs. that is totally unique. so next to their first aid kit th are going to have a little nasal spray injector of narcan. >> interesting. dr. steiger, with all of these options out there, is there a

particular treatment strategy that works t best in you experience? >> well, i'm biased because i clinic so i hadone think it's the gold standard. it's been around for over 50 years. ow it works. it -- it is incredibly highly regulated, however. if you're trying to reac who don't have access to it, you're going to ksve other trp your sleeve and that's where buprenorphine is very effective, almost as effective. think the key thing to know is not being in treatment is extremely risky. risk of death, all cause mes the mortality, mostly driven by overse, but all cause mortality goes up if you're not in treatment for opioid use disorder. we'd like to say that people can do really, really well without any medication, but that doesn't happen th often. >> you can't quit cold turkey nkts you can't quit cold turkey. much of the attention has

been focused on medical doctors prescribing thesetdrugs, what about other medical professionals like densts? are weoverlooking those other specialties in the fight againsi ops? >> at the end of the obama administration there was legislation that allowed nurse practitioners and physicians to prescribe buprenorphine. they should be ablea to to people to reduce harm from their use. >> we will have to lea it there. dr. scott steiger,a la kleiver and brian with marin county council. on tuesday president trump announced he will withdraw the u.s. from the iran nuclear deal signed in 2015. this was one of pres ent obamay foreign policy achievements. it requires that iran never builds nuclear weapons. in exchange, the u.s. would lift sanctions that have severely

stifled iran's nucle growth. to discuss this i'm joined now by professor abas fmaladm stafford university and a fellow at the hoover institution. professor malani, nice to have you here. >> nice to be here. >> on thursday tensions between iran and israel escalated as israeli war planes attacked dozens of iranian war targets inside of syria. what role would you say the u.s. pulling out of the iran nuclear deal played in that? >> i ink it's what part of the same dance, a complicated dance at i think was coordinated between israel and the united states. it began with benjamin netanyahu's conference or show where he talked about all the new intelligence that they had found in iran indicating that iran had lied about its military component, the nuclear program in the past, something that mr. trump quoted in his decision

talk and i think behind the enenes mr. trump has given israel the gr light to go at iran in syria. >> but didn't iran,ouknow, fire first? you know, fire some missiles into golan heights? it wasn't like -- and that happened before the u.s. announced its decision to withdraw from the nuclear deal. >> right. iran certainly has taken aggressive actions insyria, and it has taken aggressive actions against israel in lebanon. iran has now placed abut 200,000 missiles right on th neighborhood, right on the border of israel. israel is clearly worried about all of thi the immediate action that seems to have begotten the israeli attack is the firing of some 20 missilesnto the golan heights. they hurt nobody fortunately. ey destroyed very little but israel decided to respond massively and make thepoint.

>> so the big question now is with the u.s. withdrawing from n the i nuclear deal, does this raise the likelihood of war? >> i think it does. i think it raises the likelihood of much more serious confrontation between iran and israel and syria. i think it raies the likelihood of moren serious confrontat between iran and saudi arabia and yemen or otherhe places they are engaged in a proxy war. whasti think mitigates agai the possibility of a war is that i think that iranian regime doesn't really want a war right now. i think there are very few economic conditions. i think israel kno this, i think the trump administration knows this, i think everybody else in the region knows this and when you have as much of the economy as iran has andyou have as much of a disgruntled

population a r thegime in iran faces, the idea of picking a jor battl with israel or the united states is not happy news. >> what do you ma then of israel's -- iran's position, rather, its assertion that it is ready to rstart its nuclear program if this deal falls apart following the u.s. pulheng out ofdeal? is that just a scare tactic at this point? >> i think it was a scare tactic. it was trying to tell trump administration not to rock the boat. uhey said we will restart our nuclear program force. we will do things you don't know yet kind of clearlanguage, but actually once trump pulled out, they said we're going the deal. we are now going to try to make it work with the europeans, wi russia, with china, with the u.n., with the iea. all of these forces and institutions want the deal to t continue, anis puts the united states as the odd person t. >> doesn the trump administration though have a

point when it says this deal is flawed? for example, it did a notress a number of issues, including iran's role in syria? >> i think the trump administration on that point is right. i was one of those people who thought that this deal is the least bad deal, butt was a -- the least bad deal possible and the lea bad deal possible was clearly better than no deal. and the way you fix a bad deal is not walking away from it. you would have a lot more leverage, th united states would have had a lot more leverage if it had stayed in the deal and tried to get the europeans, tried to get russia, ied to getchina to bring some eressure on iran to make the concessions that rump administration needed. to walk away from itnt eslly gives the iranian regime someone to blame for their economic re fai it gives the iranian radicals an expse to cl down on the people and they've already begun

to do that. whoeakens the very people are the only viable force who can make a regime change in ir . the iranian people are the only people who can make the change that we all need, more democratic iran. united states can't dictate that and to ween the israeli forces by walking away from it so unilaterally and so unreasonably, well, to mewas the worst way to fix the flawed deal. >> we have about 30 seconds remaining. i have to ask you this oh. we have north korea looming. we have the talks now. it's beenanunced that that meeting between the u.s. and north korea will take place in singapore next month. what impact could this withdrawal from the iran de have hose talks with north korea. >> one way for north korea to think that if the united states can lk awayrom a deal that everyone else says is working, why wouli want to make deal with them?

why would i want to trust an administration thaks w away from such a good deal? the other option is for them to think, trump is not very -- >> not trustworthy? >> trustwortht tris not very predictable, so the mad leade theory. play the mad, scareverybody into doing what you want them to do ledo you something even more unexpected. >> we'll have to leave it eere. prsor abas malani, thank you for joining us. >> my pleasure. turning now to tech. a goup of u.c. berkeley students are using their tech skills to fight terrorism. theyted archer, a nonprofit that builds tool to track connectionsbetween terror organizations and sanctions violations among other things. the inspiration behind their nonprofites personal for th students. in 2016 two fellow u.c. berk classmates died in terrorist attacks, one in france and one in bangladesh.

today nearly 2 dozen u.c. berkeley students donate their time. they're using data to fort worth human rights abuses, corruption and money joining me are the founders of archer, tyler hines is a junior and alice ma who graduated last year from u.c. rkeley. welcome to you all. alice, let's begin with you. you founded archer along with tyler and angelie. wwhat is it and does it work? >> archer builds data alysis software for investigators who look at corruption, terror finance, war crimes and human rights. it's a subset amongst a larger set that we find systemic and criminal. we do this in a dual approach. the first is to our flagship product architect which tyler will have some thoughts on and the second is through the partnership's model where we talk toxperts who know how to generate insights from datayi tt are to investigate these issues already. >> i think we choose our

partnerships really, really carefully. in particular we'll have the human rights center at barkley. thy're holding bad actors accountable for the atrocitieou >> how areoing that? you're looking at a lot of data and putting it into a frmat that's easier for organizations to read and analyze? >> we do have a partnership like this but we have one major flagship product. we call it architect. this is a big data analysis platform and it organizes different critical public datasets into an intuitive network analys view so investigators can sort of explore connections between individuals and organizations cross borders and these are sort of just one big example of the type of tool that we build. >> and so, tyler and angelie, i know y were bothin east france when the 2016 terrorist attack happens. tyler, can you describe that experience for us? >> i'd rather not talk too much

about nice itself but it was the first time i was exposed to a problem this real, this hepactful and serious. it changed way i look at the way i spend my time and prioritize what i spend my time on. there are much more important things that i should work for than like building apps or worrying about classes. archer is something i should start rwd take d. >> angelie, what was that experience like for you? >> fore it was slightly different because the student who passed away was one of mybe friends so i was kind of already introduced to what it o would be likexperience something like this. but i think for me as well it just made it really clear that l like i can ger ignore issues of systemic security risk or human rights violations. it became urgent that i participate in combatting that, yeah. >>il as you try to these tools to help, you know, make the links between various terrorist organizations and who are the sanctions violators and

how they're related to each other, alice, what challenges do you >> so i think the challenges that we encounter are twofold. there's on on the sid of -- there's literally just so much public data that's out there and the data has been exponentially growing in the last ten years. i think that's arder context behind why archer exists and why it's iactful, because we discovered that the newsrooms or the analysts orno the rofits that are working on these issues are no longer able to keep upor with the ition that's out there. so that's kind of how we are like making an inhervention in space, i guess. and that's extremely challenging because of just how ch data is out there and how messy it can be. even with the shared manpower required to kind of gather it altogether and integrate it well, i would say that's one major challenge on a more thematic side for us. i guess it's something we've overcome thanks to like the ingenuity of theerkeley

students on our team. besides ourselves, there's 19 other students that dedicate their time to this and that actually brings me into a second challenge that i think is really himportant, whis like making an impact in this space when we're students. people always ask us, oh, you're a student so do you -- what do you do? u ke does it actually work? and, yknow, how much time do you spend on it? and i think we've overcome this as well withhe help of our team and just being completely dedicated and building a produco that speaks itself. >> you're all volunteering your time and s you've inme ways devoted more than a full-time schedule to this. tyler, when you were developing these tools, what surprised you the most? what did you learn from it? >> what really surprised me is that there are all these tdifferentcities happening in the world and there's so much information collected about them. however, there's so little work being dost because of the tools and the accessibility rooms, t there for news journal lists, for people who

society. ved in civil >> human rights organizations. >> human rights organizations. there's no way for pple to analyze organizations in this way. we're trying to bring about tools to change that. >> i thinkhat surprised us, too, is the fact that we were trying to do something aboutis quite daunting. the three of us didn't really care but getting people -- we thought it was going to be hard to convince people to donate their time essentially. they wereetting six figure offers or whatever. it's been really easy. we have kidsho are like taking their finals this week and also on client calls and alsog spend40 plus hours so that was a nice surprise. >> and who is using your tools right now? and have you been able to connect with any federal agen es? >> so - >> okay. so the product that we just launched a month ago is called sanctions explorer. it makes u.s. treasury data accessible and inciteinciteful. the users are journalists, people that work at academic

centers that work on nonproliferation issues. analysts that work on illit nance or sanctions evasion to north korea. these are a subset of our users. i think we have reached out to the government, like the u.s. treasury regarding this particular tool many times. we haven't, you knw, been actively engaged there honestly. weem visited t last spring before we started archer because we demoed several projets that we had built to the department of treasury, and they were very excited about it but i guess we just kind of fell out of touch. >> so does that lack ofcontact change anything for you? are you still hopeful that this is an opportunity toidge the gap between the bay area's tech epicenter, what you're doing, and policies bing made in washington, d.c.? >> i think, eyeah, day that we launched i was sitting in class and our twitter was just i guess blowing up because of all the people -- like all the re

people who w really excited that this existed for them. so it hasn't been like discouraging or anything. like we really understood the immediate 24 hours after we launched sanction explorer li we can have a considerable impact. >> i know you're attending rights con next in the meantime you're looking ahead, tyler, as you're ivolunteering on where would you like to take archer from here? >> so over the next few months us three are going to be going full time. that's a big jump for us going utfrom students we're going with the full commitment, going to this conference and our bi focus is to get our products in the hands of as many impactful users as possible and to learn about their problems and impacting that. money?ling and making >> yeah. so a big focus for the next couple of months is also architect, our flagship product, which integrates different

andical public datasets makes them connected so that's what we're focusing aon. right. good luck to all of you. alice ma, tyler hines and angel that will do it for us as always. you can find more of our coverage at kqed.org. i'm thuy vu. thanks for joining us.

robert: theummit is set, june 12 in singapore. presidt trump and the north korean leader together. i'm robert costa. we discuss the hopes and kallenges of u.s. foreign policy in norea and with the iran nuclear deal. tonight on "washington week." president trump: i'll be meeting with kim jong-un to pursue a future o peace and security for the world, for the whole world. barry: north korea frees three north northwestern detainees, clearing the way for the summit with kim jong-un. president trump: our biggest achievement wh will be when we denuclearize that entire region. robert: can the president